Clinical Trials

Showing trials with last updates posted in 2026.

NCT07226011 | ACTIVE_NOT_RECRUITING | NA
20 participants

Accelerated High-Dose tDCS for Depression

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2025-12-15
Completion:
2026-12-28
Conditions
  • Major Depression
  • Major Depression Disorders
Interventions
  • DEVICE
No Results Yet
NCT07221292 | RECRUITING | PHASE3
60 participants

Pivotal Study of N-acetyl-L-leucine for CACNA1A

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2026-08-17
Completion:
2027-05-01
Conditions
  • CACNA1A
  • Spinocerebellar Ataxia Type 6
  • Episodic Ataxia Type 2
  • Familial Hemiplegic Migraine-1
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT07213791 | RECRUITING | PHASE1
241 participants

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2025-10-22
Completion:
2028-07-31
Conditions
  • Ovarian Neoplasms
  • Breast Neoplasms
  • Pancreatic Intraductal Neoplasms
  • Colorectal Neoplasms
  • Esophageal Neoplasms
  • Stomach Neoplasms
  • Cholangiocarcinoma
Interventions
  • DRUG
No Results Yet
NCT07144280 | RECRUITING | PHASE3
680 participants

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2025-09-29
Completion:
2028-03-10
Conditions
  • Non-small Cell Carcinoma
  • Non-Small Cell Lung Cancer Metastatic
  • Non-Small Cell Lung Carcinoma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page